Thyroxine and reserpine-induced changes in metabolic profiles of rat urine and the therapeutic effect of Liu Wei Di Huang Wan detected by UPLC-HDMS

被引:152
作者
Wang, Ping [1 ]
Sun, Hui [1 ]
Lv, Haitao [1 ]
Sun, Wenjun [1 ]
Yuan, Ye [1 ]
Han, Ying [1 ]
Wang, Dongwu [1 ]
Zhang, Aihua [1 ]
Wang, Xijun [1 ]
机构
[1] Heilongjiang Univ Chinese Med, Natl TCM Key Lab Serum Pharmacochem, Harbin 150040, Peoples R China
关键词
Metabonomics; UPLC-HDMS; Liu Wei Di Huang Wan; Kidney yin deficiency; L-LYSINE; PLASMA;
D O I
10.1016/j.jpba.2010.04.032
中图分类号
O65 [分析化学];
学科分类号
070302 [分析化学];
摘要
The promise of metabonomics. a new "omics" technique, to validate Chinese medicines and the compatibility of Chinese formulas has been appreciated. The present study was undertaken to explore the excretion pattern of low molecular mass metabolites in the male Wistar-derived rat model of kidney yin deficiency induced with thyroxine and reserpine as well as the therapeutic effect of Liu Wei Di Huang Wan (LW) and its separated prescriptions, a classic traditional Chinese medicine formula for treating kidney yin deficiency in China The study utilized ultra-performance liquid chromatography/electrospray ionization synapt high definition mass spectrometry (UPLC/ESI-SYNAPT-HDMS) in both negative and positive electrospray ionization (ESI) At the same time, blood biochemistry was examined to identify specific changes in the kidney yin deficiency Distinct changes in the pattern of metabolites, as a result of daily administration of thyroxine and reserpine, were observed by UPLC-HDMS combined with a principal component analysis (PCA). The changes in metabolic profiling were restored to their baseline values after treatment with LW according to the PCA score plots Altogether, the current metabonomic approach based on UPLC-HDMS and orthogonal projection to latent structures discriminate analysis (OPLS-DA) indicated 20 ions (14 in the negative mode, 8 in the positive mode, and 2 in both) as "differentiating metabolites" Crown Copyright (C) 2010 Published by Elsevier B V All rights reserved
引用
收藏
页码:631 / 645
页数:15
相关论文
共 29 条
[1]
METHOD FOR MEASURING ENDOGENOUS 3-O-METHYLDOPA IN URINE AND PLASMA [J].
ARMANDO, I ;
GROSSMAN, E ;
HOFFMAN, A ;
GOLDSTEIN, DS .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 568 (01) :45-54
[2]
Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits [J].
Behr-Roussel, D ;
Rupin, A ;
Simonet, S ;
Bonhomme, E ;
Coumailleau, S ;
Cordi, A ;
Serkiz, B ;
Fabiani, JN ;
Verbeuren, TJ .
CIRCULATION, 2000, 102 (09) :1033-1038
[3]
GUO C, 1988, J AMI ACID, V5, P21
[4]
Global metabolic profiling analysis on human urine by UPLC-TOFMS: Issues and method validation in nutritional metabolomics [J].
Guy, Philippe A. ;
Tavazzi, Isabelle ;
Bruce, Stephen J. ;
Ramadan, Ziad ;
Kochhar, Sunil .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2008, 871 (02) :253-260
[5]
Reducing renal accumulation of single-chain Fv against melanoma-associated proteoglycan by coadministration of L-lysine [J].
Hamilton, S ;
Odili, J ;
Wilson, GD ;
Kupsch, JM .
MELANOMA RESEARCH, 2002, 12 (04) :373-379
[6]
MetaboliteDetector: Comprehensive Analysis Tool for Targeted and Nontargeted GC/MS Based Metabolome Analysis [J].
Hiller, Karsten ;
Hangebrauk, Jasper ;
Jager, Christian ;
Spura, Jana ;
Schreiber, Kerstin ;
Schomburg, Dietmar .
ANALYTICAL CHEMISTRY, 2009, 81 (09) :3429-3439
[7]
JIANG C, 1981, STUDIES KIDNEY CHINE
[8]
KIKUCHI T, 1981, CLIN CHEM, V27, P1899
[9]
KUANG A, 1984, J INTEGRATED TCM WM, V4, P742
[10]
Renal artery resistance index, thyroid hormones, and thyroid volume in the early kidney transplants recipients [J].
Lebkowska, U ;
Malyszko, J ;
Brózsko, S ;
Lebkowski, W ;
Malyszko, JS ;
Janica, J ;
Kowalewski, R ;
Gacko, M ;
Mysliwiec, M ;
Walecki, J .
TRANSPLANTATION PROCEEDINGS, 2006, 38 (01) :62-65